- info@myglp1store.com
- +1 (904) 942-2327
- 6953 Powers avenue suite 19 Jacksonville Fl 32217
Need Any Help?
+1 (904) 942-2327
+1 (904) 942-2327
Price range: $325.00 through $3,120.00
Tirzepatide is a synthetic dual-agonist peptide supplied exclusively for laboratory and in-vitro research involving GLP-1 and GIP receptor signaling pathways. This compound is intended strictly for experimental research applications and is not approved for human or veterinary use.
Ingredients / Composition:
| Component | Description |
|---|---|
| Active Compound | Tirzepatide (synthetic dual-agonist peptide targeting GLP-1 and GIP receptors) |
| Net Peptide Content | 60 mg per vial |
| Form | Lyophilized powder |
| Excipients | None added unless otherwise specified |
| Purity Verification | Analytical confirmation via HPLC or mass spectrometry |
Tirzepatide is referenced in scientific literature for studies examining ligand-receptor interactions, intracellular signaling activation, and metabolic pathway modulation in controlled laboratory experiments. All references are provided strictly for scientific context and experimental design and do not imply dosing or human-use guidance.
This product is intended for research purposes only. It is designated strictly for in vitro testing and laboratory experimentation and is not approved for human or animal consumption. All information provided on this website is for educational and informational purposes only. This product should be handled only by licensed and qualified professionals. It is not a drug, food, or cosmetic, and must not be misbranded, misused, or mislabeled as such.
Tirzepatide is a dual-agonist peptide designed for laboratory research on GLP-1 and GIP receptor signaling. Its molecular structure enables researchers to investigate receptor binding kinetics, intracellular signal transduction, and downstream metabolic pathway responses in controlled experimental systems.
Tirzepatide may be utilized in experimental studies including:
GLP-1 and GIP receptor binding kinetics
Intracellular signaling cascade analysis
Secondary messenger and gene expression response evaluation
Comparative dual-agonist peptide structureāactivity relationship studies
Stability, degradation, and formulation research
These studies allow for mechanistic investigations into dual-incretin receptor function and associated cellular signaling networks.
Store under laboratory-appropriate cold conditions to maintain compound stability. Handle using standard laboratory peptide protocols. Reconstitution, aliquoting, and storage should follow institutional guidelines.
This product is provided strictly for laboratory and scientific research use. Not intended for:
Human consumption
Animal use
Diagnostic procedures
Therapeutic or clinical applications
No physiological, medical, or performance outcomes are implied or guaranteed. Researchers are responsible for institutional and regulatory compliance when handling investigational compounds.
Tirzepatide is a synthetic dual-agonist peptide supplied exclusively for laboratory and in-vitro research involving GLP-1 and GIP receptor signaling pathways. This compound is intended strictly for experimental research applications and is not approved for human or veterinary use.
Ingredients / Composition:
| Component | Description |
|---|---|
| Active Compound | Tirzepatide (synthetic dual-agonist peptide targeting GLP-1 and GIP receptors) |
| Net Peptide Content | 60 mg per vial |
| Form | Lyophilized powder |
| Excipients | None added unless otherwise specified |
| Purity Verification | Analytical confirmation via HPLC or mass spectrometry |
Tirzepatide is referenced in scientific literature for studies examining ligand-receptor interactions, intracellular signaling activation, and metabolic pathway modulation in controlled laboratory experiments. All references are provided strictly for scientific context and experimental design and do not imply dosing or human-use guidance.
Reviews
There are no reviews yet.